Clinical trial
A Double-Blind, Placebo-Controlled, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of KP-1461 in HIV+ Adults Who Have Failed Two or More Highly Active Antiretroviral Regimens (HAART)
NCT00129194 is registered in ClinicalTrials.gov with Koronis Pharmaceuticals. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of KP-1461 in HIV+ Adults Who Have Failed Two or More Highly Active Antiretroviral Regimens (HAART)
- Lead sponsor
- Koronis Pharmaceuticals.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- Not reported
- Enrollment
- 40 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.